NATCOPHARM
Natco Pharma Limited
Pharmaceuticals
Share price
₹814
Market cap
₹16,027 Cr
1Y return
▼ 6%
A vertically integrated pharmaceutical company engaged in developing, manufacturing, and marketing complex products for niche therapeutic areas. Natco Pharma operates across three core business segments: finished dosage formulations, active pharmaceutical ingredients, and contract manufacturing services. The company maintains a strong research and development focus to drive innovation and develop specialized therapeutic solutions across oncology, cardiovascular, gastroenterology, and other critical therapeutic domains.
Investors holding Natco Pharma Limited
Recent moves 15
Moves15
11moves in the last 30 days
Members onlyIncluding 2 new positions
Unlock all 11 movesTata Mutual FundNew position
Tata Mutual Fund raised its stake in Natco Pharma to 1.03%, up from under 1% in the prior period, now holding 18,38,744 shares.
Read more
Durga Devi NannapaneniDecreased
Promoter Durga Devi Nannapaneni sold 50,000 shares of Natco Pharma in an off-market transaction, decreasing her stake from 1.98% to 1.95%.
Read more
LICNew position
LIC initiated a new position in Natco Pharma, acquiring 40,09,317 shares, representing a 2.24% stake.
Read more
SANJAY NANNAPANENI and SATYA VANI NANNAPANENIDecreased
Sanjay Nannapaneni and Satya Vani Nannapaneni sold 1.15 lakh shares of Natco Pharma for ₹11.63 Cr at ₹1017.31 apiece, reducing the promoter group's stake from 0.13% to 0.09%.
Read more
Track the whales in Natco Pharma Limited
Get alerted the moment a top investor buys or sells.
Start 7 days for ₹1